These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 29301553)

  • 21. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia.
    Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development.
    Konig H; Zeidner JF
    Curr Cancer Drug Targets; 2020; 20(7):471-472. PubMed ID: 32703130
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
    Naqvi K; Konopleva M; Ravandi F
    Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute myeloid leukemia].
    Döhner K; Paschka P; Döhner H
    Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies for relapsed acute myeloid leukemia: fertile ground for translational research.
    Dinner SN; Giles FJ; Altman JK
    Curr Opin Hematol; 2014 Mar; 21(2):79-86. PubMed ID: 24419335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Changes During Acute Myeloid Leukemia (AML) Evolution and Identification of Novel Treatment Strategies Through Molecular Stratification.
    Karjalainen E; Repasky GA
    Prog Mol Biol Transl Sci; 2016; 144():383-436. PubMed ID: 27865463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Laing AA; Harrison CJ; Gibson BES; Keeshan K
    Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment for acute myelogenous leukemia.
    DiNardo CD; Cortes JE
    Expert Opin Pharmacother; 2015 Jan; 16(1):95-106. PubMed ID: 25480777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation therapy for myeloid malignancies: beyond cytotoxicity.
    Stubbins RJ; Karsan A
    Blood Cancer J; 2021 Dec; 11(12):193. PubMed ID: 34864823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.
    Medinger M; Lengerke C; Passweg J
    Cancer Genomics Proteomics; 2016 09-10; 13(5):317-29. PubMed ID: 27566651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reasons for optimism in the therapy of acute leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2015; 28(2-3):69-72. PubMed ID: 26590761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapeutics in acute myeloid leukemia.
    Sweet K; Lancet JE
    Curr Hematol Malig Rep; 2014 Jun; 9(2):109-17. PubMed ID: 24633743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Myeloid Leukemia: Past, Present, and Prospects for the Future.
    Short NJ; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S25-9. PubMed ID: 27521321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving toward targeted therapies in acute myeloid leukemia.
    Gao W; Estey E
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy in acute myeloid leukaemia: current status and future directions.
    Stapnes C; Gjertsen BT; Reikvam H; Bruserud Ø
    Expert Opin Investig Drugs; 2009 Apr; 18(4):433-55. PubMed ID: 19335274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukaemia genomics.
    Medinger M; Passweg JR
    Br J Haematol; 2017 Nov; 179(4):530-542. PubMed ID: 28653397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.